Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
No differences were observed in the distribution of G894T (Glu298Asp) NOS3 genotypes between the resistant hypertension group and the controlled hypertension patients.
|
19650939 |
2009 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Second, an ANOVA was used to test the significance of an association between eNOS genotype and the level of blood pressure within the entire population except for 167 hypertensive subjects who had been under treatment for hypertension.
|
10205226 |
1999 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Salt intake affects the relation between hypertension and the T-786C polymorphism in the endothelial nitric oxide synthase gene.
|
16364825 |
2005 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Endothelial nitric oxide synthase genetic variation and essential hypertension risk in Han Chinese: the Fangshan study.
|
18769442 |
2009 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
With regard to the Glu298Asp polymorphism in NOS3, the odds ratio for the presence of hypertension in individuals having the Glu/Glu genotype of NOS3 when compared with those having the other genotypes (Asp/Asp and Asp/Glu) was 2.79.
|
19373110 |
2009 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Associations of NOS3 polymorphisms with hypertension, preeclampsia, stroke, and diabetes remain uncertain.
|
17018701 |
2006 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
The results of the present study support that homozygosity for +G894T (E298D) in NOS3 is a genetic risk factor for the development of LVH in patients with hypertension.
|
19132956 |
2009 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Although endothelial nitric oxide synthase (eNOS) haplotypes have been associated with hypertension, it is unknown whether eNOS genotypes/haplotypes are associated with resistance to antihypertensive therapy.
|
17082721 |
2006 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Previous studies regarding endothelial nitric oxide synthase (eNOS) Glu298Asp polymorphism focused upon its relation to hypertension.
|
17594145 |
2007 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
The endothelial nitric oxide synthase (eNOS) (4a/b) gene polymorphism contributes to coronary heart disease and hypertension risk.
|
12923396 |
2003 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD.
|
14682408 |
2003 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
LHGDN |
[NOS3 gene polymorphism and left ventricular hypertrophy in patients with essential hypertension].
|
12494183 |
2002 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.
|
22470539 |
2012 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men.
|
17563560 |
2007 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications.
|
27557897 |
2016 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Glu298Asp polymorphism of the endothelial nitric oxide synthase (eNOS) gene (NOS3) has been characterized as a risk factor of hypertension and coronary artery disease.
|
21816783 |
2011 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
NOS3 T-786C was also related to hypertension (p=0.049).
|
17126309 |
2007 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
A single nucleotide variant of the angiotensinogene gene (AGT M235T) and endothelial nitric oxide synthase gene (eNOS G894T) have been associated with hypertension.
|
17977523 |
2008 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Obese subjects had a 3.27-times higher risk (OR = 3.27, 95% CI: 2.37 - 4.52) of hypertension than non-obese, and in obese the NOS3 894T allele was associated with 1.37 fold higher risk of hypertension (P = 0.031).
|
26579574 |
2015 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension.
|
18325347 |
2008 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
LHGDN |
While endothelial nitric oxide synthase (eNOS) haplotypes have been associated with HT, it is unknown whether eNOS genotypes/haplotypes are associated with altered susceptibility to HT in patients with T2DM.
|
16427644 |
2006 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Markers at the peroxisome proliferative activated receptor gamma coactivator 1α (PPARGC1A) and bradykinin β2 receptor (BDKRB2) genes were nominally associated with greater risk of hypertension, although one marker each at the BDKRB2 and endothelial nitric oxide synthase-3 (NOS3) genes were nominally associated with lower risk.
|
20944660 |
2011 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
This study did not show a strong involvement of ecNOS4 gene polymorphism, at least in the basal NO production in patients with essential hypertension, however, it indicated that ecNOS4 gene polymorphism might modulate changes in BP due to water load in patients on hemodialysis, thus indicating that these polymorphisms may be involved in the pathophysiology of volume-dependent hypertension.
|
10867538 |
2000 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
LHGDN |
NOS3 T-786C was also related to hypertension (p=0.049).
|
17126309 |
2007 |
Hypertensive disease
|
0.700 |
GeneticVariation
|
group |
BEFREE |
ART induces endothelial dysfunction and arterial hypertension by epigenetic alteration of the endothelial nitric oxide synthase (eNOS) gene.
|
28323978 |
2017 |